06/02/2023

Federated learning to predicting chemotherapy response in triple-negative breast cancer

30/01/2023

Clinical benefits with futibatinib in intra-hepatic cholangiocarcinoma

23/01/2023

PARP inhibitors in advanced prostate cancer, determining HRR genes alterations is crucial for outcomes

16/01/2023

Promising results with lurbinectedin in relapsed Ewing sarcoma

09/01/2023

Trastuzumab deruxtecan in HER2+ metastatic breast cancer

02/01/2023

SurVaxM plus adjuvant temozolomide in newly diagnosed glioblastoma

19/12/2022

The bispecific antibody zanidatamab in HER2 expressing solid tumors

12/12/2022

Fondazione Michelangelo at the San Antonio Breast Cancer Symposium

05/12/2022

Combination of olaparib and radiotherapy in triple-negative breast cancer